WHO ICTRP trial
Efficacy and safety of the Xiaoyao pill for improving the clinical symptoms of…
ISRCTN12746343 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN12746343 |
|---|---|
| Public title | Efficacy and safety of the Xiaoyao pill for improving the clinical symptoms of stagnation of liver qi (chi) and spleen deficiency |
| Scientific title | Xiaoyao pill for the treatment of stagnation of liver qi and spleen deficiency with depression: a multi-center randomized controlled double-blind trial |
| Primary sponsor | Beijing University of Chinese Medicine |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | China |
| Conditions | Mild to moderate depression with symptoms of stagnation of liver qi and spleen deficiency Mental and Behavioural Disorders Depressive episode |
| Interventions | The 108 eligible participants will be allocated to the experimental or placebo arm based on a random lottery. Participants will be required to take the medicine twice daily for four consecutive weeks and the dosage is 9 g twice a day. The… |
| Registration date | Sep 24, 2020 |
| Target size | 108 |
| Secondary IDs | Nil known;Nil known;81630104 (National Natural Science Foundation) |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: